AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49
PNEUMONIA - THE IMPACT OF RISK-FACTORS ON THE OUTCOME OF TREATMENT WITH MEROPENEM AND CEFTAZIDIME
Authors: FINCH RG PEMBERTON K GILDON KM
Citation: Rg. Finch et al., PNEUMONIA - THE IMPACT OF RISK-FACTORS ON THE OUTCOME OF TREATMENT WITH MEROPENEM AND CEFTAZIDIME, Journal of chemotherapy, 10(1), 1998, pp. 35-46
PATIENT EDUCATION AND COMMUNICATION IN NON-INPATIENT INTRAVENOUS THERAPY - A REVIEW
Authors: DAVIES JM NEWLAND AC FINCH RG
Citation: Jm. Davies et al., PATIENT EDUCATION AND COMMUNICATION IN NON-INPATIENT INTRAVENOUS THERAPY - A REVIEW, European journal of haematology, 59, 1998, pp. 18-23
ANTIBIOTIC-RESISTANCE
Authors: FINCH RG
Citation: Rg. Finch, ANTIBIOTIC-RESISTANCE, Journal of antimicrobial chemotherapy, 42(2), 1998, pp. 125-128
DESIGN OF CLINICAL-TRIALS IN SEPSIS - PROBLEMS AND PITFALLS
Authors: FINCH RG
Citation: Rg. Finch, DESIGN OF CLINICAL-TRIALS IN SEPSIS - PROBLEMS AND PITFALLS, Journal of antimicrobial chemotherapy, 41, 1998, pp. 95-102
CLINICAL-TRIALS OF ANTIBACTERIAL AGENTS - A COMMENTARY
Authors: FINCH RG BAX R
Citation: Rg. Finch et R. Bax, CLINICAL-TRIALS OF ANTIBACTERIAL AGENTS - A COMMENTARY, Journal of antimicrobial chemotherapy, 41(4), 1998, pp. 432-434
ACUTE EXACERBATION OF VASCULITIS DURING INTERFERON-ALPHA THERAPY FOR HEPATITIS C-ASSOCIATED CRYOGLOBULINEMIA
Authors: GORDON ACH EDGAR JDM FINCH RG
Citation: Ach. Gordon et al., ACUTE EXACERBATION OF VASCULITIS DURING INTERFERON-ALPHA THERAPY FOR HEPATITIS C-ASSOCIATED CRYOGLOBULINEMIA, The Journal of infection, 36(2), 1998, pp. 229-230
PRACTICAL CONSIDERATIONS AND GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA (VOL 55, PG 31, 1998)
Authors: FINCH RG WOODHEAD MA
Citation: Rg. Finch et Ma. Woodhead, PRACTICAL CONSIDERATIONS AND GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA (VOL 55, PG 31, 1998), Drugs, 55(6), 1998, pp. 777-777
PRACTICAL CONSIDERATIONS AND GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA
Authors: FINCH RG WOODHEAD MA
Citation: Rg. Finch et Ma. Woodhead, PRACTICAL CONSIDERATIONS AND GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA, Drugs, 55(1), 1998, pp. 31-45
IN-VITRO ANTIMICROBIAL SUSCEPTIBILITY TESTING - DOES IT REALLY MATTER- INTRODUCTION
Authors: FINCH RG
Citation: Rg. Finch, IN-VITRO ANTIMICROBIAL SUSCEPTIBILITY TESTING - DOES IT REALLY MATTER- INTRODUCTION, Journal of chemotherapy, 9, 1997, pp. 3-6
MEDICAL DECOMPRESSION OF VERTEBRAL HYDATIDOSIS
Authors: LAM KS FARAJ A MULHOLLAND RC FINCH RG
Citation: Ks. Lam et al., MEDICAL DECOMPRESSION OF VERTEBRAL HYDATIDOSIS, Spine (Philadelphia, Pa. 1976), 22(17), 1997, pp. 2050-2055
A COMPARISON OF MUCOSAL INFLAMMATORY RESPONSES TO GIARDIA-MURIS IN RESISTANT B10 AND SUSCEPTIBLE BALB C MICE/
Authors: VENKATESAN P FINCH RG WAKELIN D
Citation: P. Venkatesan et al., A COMPARISON OF MUCOSAL INFLAMMATORY RESPONSES TO GIARDIA-MURIS IN RESISTANT B10 AND SUSCEPTIBLE BALB C MICE/, Parasite immunology, 19(3), 1997, pp. 137-143
GREPAFLOXACIN - A VIEWPOINT
Authors: FINCH RG
Citation: Rg. Finch, GREPAFLOXACIN - A VIEWPOINT, Drugs, 53(5), 1997, pp. 825-825
ANTIBIOTIC-RESISTANCE
Authors: FINCH RG
Citation: Rg. Finch, ANTIBIOTIC-RESISTANCE, British Journal of Hospital Medicine, 57(9), 1997, pp. 472-472
OVER-THE-COUNTER DRUGS - WORKING PARTY WILL SEE WHETHER ANTIMICROBIALS SHOULD BE AVAILABLE
Authors: FINCH RG REEVES DS
Citation: Rg. Finch et Ds. Reeves, OVER-THE-COUNTER DRUGS - WORKING PARTY WILL SEE WHETHER ANTIMICROBIALS SHOULD BE AVAILABLE, BMJ. British medical journal, 313(7049), 1996, pp. 115-115
AN INTERNATIONAL COLLABORATIVE SURVEILLANCE STUDY OF COMMUNITY-ACQUIRED BACTERIAL LRTI PATHOGENS - THE ALEXANDER PROJECT - PREFACE
Authors: FINCH RG WILCOX MH WOOD MJ
Citation: Rg. Finch et al., AN INTERNATIONAL COLLABORATIVE SURVEILLANCE STUDY OF COMMUNITY-ACQUIRED BACTERIAL LRTI PATHOGENS - THE ALEXANDER PROJECT - PREFACE, Journal of antimicrobial chemotherapy, 38, 1996, pp. 5-5
A MULTINATIONAL EUROPEAN SURVEY ON THE IN-VITRO ACTIVITY OF RUFLOXACIN AND OTHER COMPARATIVE ANTIBIOTICS ON RESPIRATORY AND URINARY BACTERIAL PATHOGENS
Authors: SCHITO GC ACAR JF BAUERNFEIND A DUVAL J FINCH RG FOCHT J NICOLETTI G PHILLIPS I PRATTS G SORIANO F WIEDEMAN B WISE R
Citation: Gc. Schito et al., A MULTINATIONAL EUROPEAN SURVEY ON THE IN-VITRO ACTIVITY OF RUFLOXACIN AND OTHER COMPARATIVE ANTIBIOTICS ON RESPIRATORY AND URINARY BACTERIAL PATHOGENS, Journal of antimicrobial chemotherapy, 38(4), 1996, pp. 627-639
AZITHROMYCIN - FURTHER CLINICAL-EXPERIENCE - PREFACE
Authors: FINCH RG BROWN EM SPENCER RC
Citation: Rg. Finch et al., AZITHROMYCIN - FURTHER CLINICAL-EXPERIENCE - PREFACE, Journal of antimicrobial chemotherapy, 37, 1996, pp. 3-3
RESPONSE TO ORAL AND INTRAVENOUS AZITHROMYCIN IN A PATIENT WITH TOXOPLASMA ENCEPHALITIS AND AIDS
Authors: WISELKA MJ READ R FINCH RG
Citation: Mj. Wiselka et al., RESPONSE TO ORAL AND INTRAVENOUS AZITHROMYCIN IN A PATIENT WITH TOXOPLASMA ENCEPHALITIS AND AIDS, The Journal of infection, 33(3), 1996, pp. 227-229
INTERNATIONAL SEPSIS TRIAL (INTERSEPT) - ROLE AND IMPACT OF A CLINICAL-EVALUATION COMMITTEE
Authors: SPRUNG CL FINCH RG THIJS LG GLAUSER MP
Citation: Cl. Sprung et al., INTERNATIONAL SEPSIS TRIAL (INTERSEPT) - ROLE AND IMPACT OF A CLINICAL-EVALUATION COMMITTEE, Critical care medicine, 24(9), 1996, pp. 1441-1447
PHARMACOKINETIC BEHAVIOR OF INTRAPERITONEAL TEICOPLANIN DURING TREATMENT OF PERITONITIS COMPLICATING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
Authors: FINCH RG HOLLIDAY AP INNES A BURDEN RP MORGAN AG SHAW PN HARDING I WALE MCJ
Citation: Rg. Finch et al., PHARMACOKINETIC BEHAVIOR OF INTRAPERITONEAL TEICOPLANIN DURING TREATMENT OF PERITONITIS COMPLICATING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Antimicrobial agents and chemotherapy, 40(8), 1996, pp. 1971-1972
COMPARISON OF ANTIBODY AND CYTOKINE RESPONSES TO PRIMARY GIARDIA-MURIS INFECTION IN H-2 CONGENIC STRAINS OF MICE
Authors: VENKATESAN P FINCH RG WAKELIN D
Citation: P. Venkatesan et al., COMPARISON OF ANTIBODY AND CYTOKINE RESPONSES TO PRIMARY GIARDIA-MURIS INFECTION IN H-2 CONGENIC STRAINS OF MICE, Infection and immunity, 64(11), 1996, pp. 4525-4533
EPIDEMIOLOGY, CONTROL AND TREATMENT OF MULTIRESISTANT GRAM-NEGATIVE RODS - DISCUSSION
Authors: FINCH RG WIEDEMANN B GLAUSER MP DAVEY PG HOIBY N
Citation: Rg. Finch et al., EPIDEMIOLOGY, CONTROL AND TREATMENT OF MULTIRESISTANT GRAM-NEGATIVE RODS - DISCUSSION, Drugs, 52, 1996, pp. 100-102
EPIDEMIOLOGY, CONTROL AND TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS - DISCUSSION
Authors: FINCH RG CHAULET P KLUGMAN KP
Citation: Rg. Finch et al., EPIDEMIOLOGY, CONTROL AND TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS - DISCUSSION, Drugs, 52, 1996, pp. 107-108
ANTIBACTERIAL ACTIVITY OF QUINUPRISTIN DALFOPRISTIN - RATIONALE FOR CLINICAL USE
Authors: FINCH RG
Citation: Rg. Finch, ANTIBACTERIAL ACTIVITY OF QUINUPRISTIN DALFOPRISTIN - RATIONALE FOR CLINICAL USE, Drugs, 51, 1996, pp. 31-37
NEW STRATEGIES IN INFECTIOUS-DISEASES - RATIONALE FOR THE USE OF NOVEL STREPTOGRAMINS - A SEMINAR-IN-PRINT - QUESTIONS AND ANSWERS
Authors: APPELBAUM PC CORMICAN MG JONES RN VANNUFFEL P COCITO C PECHERE JC FINCH RG RUBINSTEIN E
Citation: Pc. Appelbaum et al., NEW STRATEGIES IN INFECTIOUS-DISEASES - RATIONALE FOR THE USE OF NOVEL STREPTOGRAMINS - A SEMINAR-IN-PRINT - QUESTIONS AND ANSWERS, Drugs, 51, 1996, pp. 43-45
Risultati: 1-25 | 26-49